Dr. Zimmerman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
896 Old Country Rd
Riverhead, NY 11901Phone+1 631-846-5250
Education & Training
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2015 - 2018
Weill Cornell MedicineClass of 2015
Certifications & Licensure
NY State Medical License 2017 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Correlating Predicted Adjuvant Therapy Benefit and Risk of Recurrence Between Breast Cancer Index (BCI) and the 21-Gene Oncotype DX Recurrence Score (RS).Nicole Casasanta, Rima Patel, Samantha Raymond, Melanie W Kier, Julia Blanter
Clinical Breast Cancer. 2024-10-01 - 4 citationsNext-Generation HER2-Targeted Antibody-Drug Conjugates in Breast Cancer.Brittney S Zimmerman, Francisco J Esteva
Cancers. 2024-02-16 - 3 citationsCorrelation of the Ki67 Working Group prognostic risk categories with the Oncotype DX Recurrence Score in early breast cancer.Rima Patel, Malin Hovstadius, Melanie W Kier, Erin L Moshier, Brittney S Zimmerman
Cancer. 2022-10-01
Press Mentions
Experts Available and Research to Be Presented in Bladder Cancer, Disparities in Cancer and Other Areas at the 2021 ASCO Annual MeetingMay 19th, 2021- SABCS 2020: Managing Breast Cancer During the COVID-19 PandemicDecember 9th, 2020
- During the Pandemic, Cancer Care Has Taken a Hit, Researchers Say at San Antonio Breast Cancer SymposiumDecember 8th, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
